share_log

HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target

Benzinga ·  May 6 06:42

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment